These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29627483)

  • 1. Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells.
    van den Berge M; Jonker MR; Miller-Larsson A; Postma DS; Heijink IH
    Pulm Pharmacol Ther; 2018 Jun; 50():47-56. PubMed ID: 29627483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide and fluticasone propionate differentially affect the airway epithelial barrier.
    Heijink IH; Jonker MR; de Vries M; van Oosterhout AJ; Telenga E; Ten Hacken NH; Postma DS; van den Berge M
    Respir Res; 2016 Jan; 17():2. PubMed ID: 26739349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3).
    Borchard G; Cassará ML; Roemelé PE; Florea BI; Junginger HE
    J Pharm Sci; 2002 Jun; 91(6):1561-7. PubMed ID: 12115854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Virus-Induced Cytokine Production from Airway Epithelial Cells by the Late Addition of Budesonide.
    Homma T; Fukuda Y; Uchida Y; Uno T; Jinno M; Kishino Y; Yamamoto M; Sato H; Akimoto K; Kaneko K; Fujiwara A; Sato H; Hirai K; Miyata Y; Inoue H; Ohta S; Watanabe Y; Kusumoto S; Ando K; Suzuki S; Yamaoka T; Tanaka A; Ohmori T; Sagara H
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids.
    Atsuta J; Plitt J; Bochner BS; Schleimer RP
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):643-50. PubMed ID: 10100995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
    Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
    Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function.
    Belchamber KB; Thomas CM; Dunne AE; Barnes PJ; Donnelly LE
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2883-2897. PubMed ID: 30271135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate.
    Provost KA; Smith M; Miller-Larsson A; Gudleski GD; Sethi S
    PLoS One; 2019; 14(1):e0207675. PubMed ID: 30677037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
    Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
    Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate and Salmeterol combination induces SOCS-3 expression in airway epithelial cells.
    Nasreen N; Khodayari N; Sukka-Ganesh B; Peruvemba S; Mohammed KA
    Int Immunopharmacol; 2012 Jan; 12(1):217-25. PubMed ID: 22155101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures.
    Sabatini F; Silvestri M; Scarso L; Brazzola G; Rossi GA
    J Asthma; 2002 Feb; 39(1):11-20. PubMed ID: 11883735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H; Yamase H
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol and fluticasone propionate combination improves histone deacetylation and anti-inflammatory activities in bronchial epithelial cells exposed to cigarette smoke.
    Ferraro M; Gjomarkaj M; Siena L; Di Vincenzo S; Pace E
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1718-1727. PubMed ID: 28483577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono- and Cocultures of Bronchial and Alveolar Epithelial Cells Respond Differently to Proinflammatory Stimuli and Their Modulation by Salbutamol and Budesonide.
    Haghi M; Hittinger M; Zeng Q; Oliver B; Traini D; Young PM; Huwer H; Schneider-Daum N; Lehr CM
    Mol Pharm; 2015 Aug; 12(8):2625-32. PubMed ID: 26147243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
    Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
    Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells.
    Huang YC; Leyko B; Frieri M
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):443-51. PubMed ID: 16312167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
    Price DB; Williams AE; Yoxall S
    Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.